Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;7(2):77-82.
doi: 10.2174/157015909788848866.

Antiepileptic drug monotherapy: the initial approach in epilepsy management

Erik K St Louis  1 , William E Rosenfeld, Thomas Bramley
Affiliations

Antiepileptic drug monotherapy: the initial approach in epilepsy management

Erik K St Louis et al. Curr Neuropharmacol. 2009 Jun.

Abstract

Antiepileptic drug (AED) monotherapy is the preferred initial management approach in epilepsy care, since most patients may be successfully managed with the first or second monotherapy utilized. This article reviews the rationale and evidence supporting preferential use of monotherapy when possible and guidelines for initiating and successfully employing AED monotherapy. Suggested approaches to consider when patients fail monotherapy include substituting a new AED monotherapy, initiating chronic maintenance AED polytherapy, or pursuit of non-pharmacologic treatments such as epilepsy surgery or vagus nerve stimulation. Reducing AED polytherapy to monotherapy frequently reduces the burden of adverse effects and may also improve seizure control. AED monotherapy remains the optimal approach for managing most patients with epilepsy.

Keywords: New onset epilepsy; antiepileptic drugs; monotherapy; titration..

PubMed Disclaimer

References

    1. American Academy of Neurology Guideline Summary for Clinicians. Management Issues for Women with Epilepsy. [Accessed March 5, 2006];Available at: www.aan.com .
    1. Anderson GD, Gidal BE, Messenheimer JA, Gilliam FG. Time course of lamotrigine de-induction: impact of stepwise withdrawal of carbamazepine or phenytoin. Epilepsy Res. 2002;49:211–217. - PubMed
    1. Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE. EPMN-106/INT-28 Investigators. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol. Scand. 2005;112(4):214–222. - PubMed
    1. Boon P, D'Havé M, Van Walleghem P, Michielsen G, Vonck K, Caemaert J, De Reuck J. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia. 2002;43:96–102. - PubMed
    1. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res. 1999;37(1):81–87. - PubMed

LinkOut - more resources